Cardiol Therapeutics Inc (TSE:CRDL)
North American company
Share Price Chart
- Chart currently unavailable -
Market Info - CRDL
- Market Open Price0.00
- Previous Close0.00
- Volume-
- 52w Low/High-
- Last Trade Price0.00
- Bid/Ask Price0.00
Company Info - CRDL
- Market CapCAD112.870m
- SymbolTSE:CRDL
- IndustryHealthcare
- SectorDrug Manufacturers - Specialty & Generic
- Currency
- ISINCA14161Y2006
Company Profile
Cardiol Therapeutics Inc is a clinical-stage biotechnology company developing therapies for inflammatory heart disease. The company has received approval to commence a Phase II/III clinical trial investigating its product, CardiolRx, in COVID-19 patients with history of cardiovascular disease. CardiolRx is a pharmaceutically produced, GMP certified, THC free (<10 ppm) oral cannabidiol formulation.
Latest CRDL news
Currently there for this company. Visit our news hub for other news .